EXC vs SRNE · P/E 17, rev $24.26B vs $385.9K cap
Exelon Corporation (EXC) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
SRNE does not have a complete income-statement cache yet.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the EXC and SRNE stock pages for the full models.
Not investment advice.